tbuckley/cabot-search huggingface dataset:
90Y-Ibritumomab-Tiuxetan Consolidation in First-Line Complete Response Follicular Lymphoma Patients. Single Center Outcomes Analysis after Five Years Median Follow-up
Authors: Marcio Andrade-Campos, Natalia Espinosa-Lara, Paola Lievano, Luis Lopez-Gomez, Teresa Baringo, Pilar Giraldo
Journal: Blood (2016)
The Predictive Value of Gene Expression Profiles for Acute Graft-Versus-Host Disease after Hematopoietic Cell Transplantation with Nonmyeloablative Conditioning for Hematological Malignancy.
Authors: Tania N. Masmas, Lennart Friis-Hansen, Jens Vilstrup Johansen, Soren Lykke Petersen, Brian T. Kornblit, Ole Winther, Finn Cilius Nielsen, Lars Vindelov
Journal: Blood (2007)
Jumping Translocation of Homogeneously Staining Region Hsr(11q) in An Erythroid Leukemia: Identification of Amplified Regions by Fluorescence Hybridization, M-FISH and M-Banding.
Authors: Catherine Helias, Carine Gervais, Eric Jeandidier, Bruno Lioure, Laurent Mauvieux
Journal: Blood (2011)
Exome Sequencing Identifies Highly Recurrent Somatic GATA2 and CEBPA Mutations in Acute Erythroid Leukemia
Authors: Suning Chen, Nana Ping, Jia Yin, Wenxiu Cheng, Qinrong Wang, Qian Wang, Liang Ma, Hong Yao, Lijun Wen, Yang Xu, Hong Liu, Zhengming Jin, Mingqing Zhu, Jianying Liang, Dandan Liu, Huiying Qiu, Aining Sun, Changgeng Ruan, Wu Depei
Journal: Blood (2015)
High Rate of Long Term Complete Remission for Patients with Chronic Lymphocytic Leukemia (CLL) Who Relapse after Allogeneic Stem Cell Transplantation and Receive Salvage with Donor Lymphocyte Infusions (DLI)
Authors: Alan P Skarbnik, Mary E DiLorenzo, Tracy Andrews, Phyllis McKiernan, Scott D. Rowley, David H. Vesole, Andre Goy, Tatyana Feldman, Lori A Leslie, Lori A. Leslie, Andrew L. Pecora, Michele L. Donato
Journal: Blood (2016)
Comorbidity and Outcomes for Patients Over Age 65 Years Treated with Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndrome
Authors: Henry J. Conter, Nhu-Nhu Nguyen, Gabriela Rondon, Julianne Chen, Elizabeth J Shpall, Issa Khouri, Sergio A Giralt, Richard E. Champlin, Marcos DeLima
Journal: Blood (2012)
ΝFΚΒΙΕ Deletions: A Novel Marker of Clinical Aggressiveness in Primary Mediastinal B-Cell Lymphoma
Authors: Daniel Noerenberg*, Larry Mansouri*, Emma Young, Frick Mareike, Maysaa Abdulla, Fazila Asmar, Blanca Gonzalez-Farre, Tasidou Anna, Nils Waldhueter, Viktor Ljungström, Alfredo Rivas, Maria K. Angelopoulou, Marita Ziepert, Christopher M. Arends, Lucile Couronne, Dido Lenze, Claudia D. Baldus, Christian Bastard, Jessica Okosun, Jude Fitzgibbon, Bernd Dörken, Hans G. Drexler, Damien Roos-Weil, Clemens A. Schmitt, Helga Duverger Munch-Petersen, Thorsten Zenz, Jonathan C. Strefford, Gunilla Enblad, Olivier A. Bernard, Elisabeth Ralfkiaer, Penelope Korkolopoulou, Magnus Hultdin, Theodora Papadaki, Kirsten Grønbæk, Armando Lopez-Guillermo, Kostas Stamatopoulos, Niki Stavroyianni, George Kanellis, Andreas Rosenwald, Elias Campo, Rose-Marie Amini, German Ott, Theodoros Vassilakopoulos, Michael Hummel, Frederik Damm**, Richard Rosenquist**
Journal: Blood (2016)
Disturbed Regulation and Activity of PI 3-Kinase Activity Due to Enhanced Lyn Kinase but Decreased Ship-1 and Gab2 Levels in Patients with Myelodysplastic Syndrome.
Authors: Daniel W. Lee, Quan-Sheng Zhu, Gus Zamora, Ogonna Nwawka, Elizabeth J. Shpall, Steven K. Kornblau, Seth J. Corey
Journal: Blood (2004)
BRCA variant classification is improved by Japanese SNP data and correlate with response to PARP inhibition in MH GUIDE
Authors: Yosuke Hirotsu, Udo Schmidt-Edelkraut, Xiaoyue Wang, Regina Bohnert, Markus Hartenfeller, Peter Koch, Andreas Werner, Ram Narang, Sajo Kaduthanam, Francesca Diella, Martin Stein, Josef Hermanns, Stephan Brock, Stephan Hettich, David Jackson
Journal: Annals of Oncology (2019)
Non-Relapse Mortality Exceeds Relapse Mortality Six Years After Autologous Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma.
Authors: Brian T. Hill, Lisa Rybicki, Brian J. Bolwell, Stephen Smith, Robert Dean, Matt E Kalaycio, Brad Pohlman, Shawnda Tench, Ronald Sobecks, Steven Andresen, Edward Copelan, John William Sweetenham
Journal: Blood (2009)
Clinical Impact of Cytokine and Chemokine Genes Polymorphisms on Outcome After Allogeneic Hematopoietic Stem Cell Transplantation
Authors: Agnieszka Tomaszewska, Katarzyna Guz, Justyna Smolarczyk-Wodzynska, Barbara Nasilowska-Adamska, Magdalena Lakomy, Piotr Rzepecki, Ewa Brojer, Bozena Marianska
Journal: Blood (2010)
Normal RUNX1 and Pathogenic ETV6/RUNX1 Compete Genome-Wide for Chromatin Binding in Pre-B Acute Lymphoblastic Leukemia
Authors: Marie-Pierre Arnaud, Stéphane Avner, Aurélien A Sérandour, Anne-Gaëlle Rio, Nicolas Mouchet, Morgane Lenrouilly, Jason S Caroll, Gilles Salbert, Marie-Dominique Galibert, Virginie Gandemer, Marie-Bérengère Troadec
Journal: Blood (2014)
Provider and Center Characteristics Of US Transplant Centers and Their Association With Survival After Allogeneic Hematopoietic Cell Transplantation (HCT) In Adults: Results From a National Survey Conducted By The Center For International Blood and Marrow Transplant Research (CIBMTR)
Authors: Navneet S. Majhail, Tammy Payton, Lih-Wen Mau, Jennifer Le Rademacher, Pintip Chitphakdithai, Michael Eckrich, Steven Joffe, Stephanie J. Lee, Charles F. LeMaistre, Fausto R. Loberiza, Brent R. Logan, Elizabeth A Murphy, Susan K. Parsons, Ramona Repaczki-Jones, J. Douglas Rizzo, Pam Robinett, Ellen Denzen
Journal: Blood (2013)
A Selective TNFR2 Agonist Expands Host Treg Cells in Vivo to Protect from Acute Graft-Versus-Host Disease
Authors: Andreas Beilhack, Martin Chopra, Marlene Biehl, Martin Vaeth, Andreas Brandl, Jorge Amich, Janina Findeis, Ana-Laura Jordán Garrote, Christian Brede, Carina A Bäuerlein, Stefanie Schwinn, Hermann Einsele, Friederike Berberich-Siebelt, Harald Wajant
Journal: Blood (2014)
Endovascular Therapy for Childhood Stroke—Working Together to Reach Prime Time
Authors: Christine Fox, Nomazulu Dlamini
Journal: JAMA Neurology (2019)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Neurology HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Neurology journal
Hammersmith Score Is Able to Identify Chronic Myeloid Leukemia Patients with Poor Prognosis Before Treatment with Second-Generation TKIs.
Authors: Massimo Breccia, Roberto Latagliata, Fabio Stagno, Antonella Gozzini, Elisabetta Abruzzese, Antonella Russo Rossi, Michelina Santopietro, Laura Cannella, Federica Sorà, Paolo Vigneri, Malgorzata Trawinska, Simona Sica, Giorgina Specchia, Valeria Santini, Giuliana Alimena
Journal: Blood (2010)
Author Correction: Postzygotic inactivating mutations of RHOA cause a mosaic neuroectodermal syndrome
Authors: Pierre Vabres, Arthur Sorlin, Stanislav S. Kholmanskikh, Bénédicte Demeer, Judith St-Onge, Yannis Duffourd, Paul Kuentz, Jean-Benoît Courcet, Virginie Carmignac, Philippine Garret, Didier Bessis, Odile Boute, Alain Bron, Guillaume Captier, Esther Carmi, Bernard Devauchelle, David Geneviève, Catherine Gondry-Jouet, Laurent Guibaud, Arnaud Lafon, Michèle Mathieu-Dramard, Julien Thevenon, William B. Dobyns, Geneviève Bernard, Satyamaanasa Polubothu, Francesca Faravelli, Veronica A. Kinsler, Christel Thauvin, Laurence Faivre, M. Elizabeth Ross, Jean-Baptiste Rivière
Journal: Nature Genetics (2019)
Activated Circulating T Follicular Helper Cells with Increased Function during Chronic Graft Versus Host Disease after Allogeneic Stem Cell Transplantation
Authors: Edouard Forcade, Haesook T. Kim, Corey S Cutler, Kathy S. Wang, Vincent T Ho, John Koreth, Philippe Armand, Edwin P. Alyea, Bruce R. Blazar, Robert J. Soiffer, Joseph H. Antin, Jerome Ritz
Journal: Blood (2015)
Further Investigation of the Role of Factor XIII in Priapism Associated with SCD.
Authors: Aya El Khatib, Allison Ashley-Koch, Melanie Kail, Ann Collins, Jude Jonassaint, Soheir S. Adam, Kenneth I. Ataga, James R. Eckman, Eugene P. Orringer, Charles S. Greenberg, Marilyn J. Telen
Journal: Blood (2007)
Immune Recovery after Timed Sequential Therapy in Acute Myelogenous Leukemia: Discordant Recovery of Naïve T Lymphocytes and Antigen Driven Regulatory T Cells.
Authors: Allan D. Hess, Christian Meyer, Christopher Thoburn, Ferdynand Kos, Christopher Gocke, Hyam Levitsky, Judith Karp
Journal: Blood (2008)
Re: Laurence Albiges, Tom Powles, Michael Staehler, et al. Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic Clear-Cell Renal Cell Carcinoma. Eur Urol 2019;76:151–6
Authors: Karlijn de Joode, Astrid A.M. van der Veldt
Journal: European Urology (2019)
Decitabine Priming Enhances Mucin 1 Inhibition Mediated Disruption of Redox Homeostasis in Cutaneous T-Cell Lymphoma
Authors: Salvia Jain, Abigail J. Washington, Rebecca Karp Leaf, Parul Bhargava, Rachael Clark, Thomas S. Kupper, Dina Stroopinsky, Athalia Rachel Pyzer, Leandra Cole, Myrna R. Nahas, Arie Apel, Jacalyn Rosenblatt, Jon Arnason, Donald Kufe, David E. Avigan
Journal: Blood (2016)
Absolute CD4+ T-Cell Count Predicts Survival in Diffuse Large B-Cell Lymphoma
Authors: Yoshiharu Kusano, Yasuhito Terui, Kengo Takeuchi, Anna Takahashi, Norihito Inoue, Hirohumi Yamauchi, Naoko Tsuyama, Kyoko Ueda, Yuko Mishima, Noriko Nishimura, Masahiro Yokoyama, Kiyohiko Hatake
Journal: Blood (2016)
NADH Dehydrogenase Subunit 4 (ND4) Mutations in Pediatric Acute Myeloid Leukemia
Authors: Michael A Morgan, Birgit Markus, Malou Hermkens, Frederik Damm, Katarina Reinhardt, Martin Zimmermann, Iris H.I.M. Hollink, MM van den Heuvel-Eibrink, C. Michel Zwaan, Felicitas Thol, Tania Bunke, Dessislava Bogoeva, Christoph WM Reuter, Arnold Ganser, Dirk Reinhardt
Journal: Blood (2012)
Iron Deficiency Modifies Gene Expression Variation Induced by Augmented Hypoxia Sensing
Authors: Victor R. Gordeuk, Xu Zhang, Wei Zhang, Shwu-Fan Ma, Galina Miasniakova, Adelina Sergueeva, Tatiana Ammosova, Min Xu, Sergei Nekhai, Josef T. Prchal, Michael Wade, Joe GN Garcia, Roberto F Machado
Journal: Blood (2012)
Phase 1b/2a Open-Label, Multiple-Dose, Dose-Escalation Study to Evaluate the Safety and Tolerability of SNS01-T Administered by Intravenous Infusion in Patients with Relapsed or Refractory Multiple Myeloma.
Authors: John A Lust, Saad Z Usmani, Mehdi Hamadani, Charles Barranco, Martha Q Lacy, Angela Dispenzieri, Morie A Gertz, David Dingli, Stephen Russell, Francis K Buadi, Steven R Zeldenrust, Suzanne R Hayman, S. Vincent Rajkumar, Shaji K. Kumar, John Thompson, Catherine A Taylor, Richard Dondero
Journal: Blood (2012)
Azacitidine Followed By Intensive Induction/Consolidation Chemotherapy in Older Patients with Acute Myeloid Leukemia (AML): Results from the Randomized AML-AZA Trial of the Study Alliance Leukemias (SAL)
Authors: Carsten Müller-Tidow, Petra Tschanter, Utz Krug, Stefanie Goellner, Christoph Röllig, Christian Thiede, Anja Koschmieder, Martin Dugas, Joachim Gerss, Trude Butterfaß-Bahloul, Ruth Wagner, Stefan W. Krause, Ulrich Kaiser, Volker Kunzmann, Björn Steffen, Richard Noppeney, Wolfgang Herr, Claudia D Baldus, Norbert Schmitz, Katharina Götze, Albrecht Reichle, Martin Kaufmann, Andreas Neubauer, Kerstin Schäfer-Eckart, Mathias Hänel, Rudolf Peceny, Haack Bea, Lilly Meredith, Norbert Frickhofen, Michael G Kiehl, Aristoteles A.N. Giagounidis, Martin Görner, Roland Repp, Ralph Naumann, Hartmut Link, Alexander Kiani, Steffen Koschmieder, Tim H. Brümmendorf, Hubert Serve, Gerhard Ehninger, Wolfgang E Berdel
Journal: Blood (2014)
The Glioma Elephant in The Room
Authors: Charles Davis
Journal: Neuro-Oncology (2019)

Abstract Radiotherapy is the most effective treatment of glioblastoma, radical surgery and chemotherapy will help some patients. Tumour Treating Fields (TTF) is used in many countries in the developed world. Thousands of patients have been treated. Methods A survey at a neuro-oncology meeting of clinicians, scientists and charity members asking them about TTF. Results 1. 7 out of 8 clinicians did not discuss TTF with patients.: 2. The reasons being “not available”, “very expensive”, “don’t know enough”.: 3. Out of 17 non clinicians, 14 stated that TTF should be discussed with all patients.: 4. Out of 22 clinicians and non clinicians, 16 said they would consider trying to raise £200.000 for treatment from crowd funding. Discussion The report of the chief scientific officer of the department of health on brain tumours, the report of the Tessa Jowell funding, BNOS, do not discuss TTF.?why. NICE guidelines for NHS patients state “Do not offer TTF” but do not say “Do not discuss”. Conclusion Sadly, clinicians are not telling the patients about options for treatment. TTF is controversial and expensive and is now being used in several cancer treatments. The UK is one of the few developed countries that is not researching or discussing this treatment.
Abstract 455: The Burmese Python as a Model of Metabolic Protection
Authors: Angela K Peter, Christopher D Ozeroff, Leslie A Leinwand
Journal: Circulation Research (2017)

Introduction: The postprandial Burmese python displays a remarkable level of cardiac adaptation to high levels of circulating triglycerides and an increased metabolic rate without any evidence of cardiac pathology. To challenge the level of cardioprotection, we designed an experiment to attempt to induce metabolic syndrome in the Burmese python. Metabolic syndrome is typically defined as obesity concomitant with other metabolic abnormalities which contribute to an increased risk for cardiovascular disease. Methods and Results: Unlike mice or rats who readily undergo hypertrophy in response to pressure-overload or β-adrenergic receptor stimulation, inducing pathological hypertrophy in the Burmese python is challenging. In the current study, we attempted to induce metabolic syndrome through overfeeding. We offered Burmese pythons a meal equivalent to 25% of the python’s body mass every 4 days for a period of 2 months. Two similar groups of pythons were maintained on our standard python feeding schedule (one meal equivalent to 25% of their body weight every 28 days) over the same time course. At the end of 2 months, the weight of the overfed pythons (6197g ± 180g) dramatically increased when compared to fasted (2352g ± 23g) or normal fed pythons (3044g ± 62g). In addition to an overall increase in body weight, the ventricle weight/brain weight ratio increased significantly in the overfed pythons (19.5 ± 1.1) compared to fasted (7.5 ± 0.2) or normal fed pythons (8.8 ± 0.2) indicating considerable hypertrophy. However, despite developing hypertrophy, there was no evidence of aberrant gene expression or impaired glucose tolerance when compared to normal fed pythons. Conclusions: Despite repeatedly consuming a large meal, nearly tripling in body weight, and developing significant hypertrophy, the Burmese python is protected from developing metabolic abnormalities such as impaired glucose tolerance. Fetal gene expression markers of pathological cardiac hypertrophy were not induced in overfed pythons. Thus, studying the mechanisms of cardiac adaptation in the Burmese python may potentially provide insights into therapeutic targets for combating metabolic syndrome in patients.
Hematogones (medullar pro-B Cells) Are Present but Decreased in Active Multiple Myeloma and Are a Prognostic Factor in Treated Myeloma Patients
Authors: Quentin Cabrera, Sylvain Chantepie, Jean-Baptiste Mear, Véronique Salaun, Edouard Cornet, Xavier Troussard, Oumedaly Reman, Margaret Macro
Journal: Blood (2014)
Whole Genome Sequencing Identifies Functional Mutations In the Wnt Pathway In CLL
Authors: Lili Wang, Nathalie Pochet, Kristian Cibulskis, Wandi Zhang, Mike Lawrence, Quinlan L. Sievers, Erica Shefler, Donna Neuberg, Stacey Gabriel, Carrie Sougnez, Aviv Regev, Gad Getz, Nir Hacohen, Jennifer R Brown, Catherine J Wu
Journal: Blood (2010)
Risk Stratification of Untreated Mantle Cell Lymphoma Patients Using MIPI, Ki67 Proliferative Index and Cytogenetics
Authors: Ashley D. Staton, Irl Brian Greenwell, Jeffrey M Switchenko, Joseph Maly, Kristie Blum, Natalie S. Grover, Stephanie Mathews, Steven I. Park, Max J. Gordon, Alexey V Danilov, Narendranath Epperla, Timothy S Fenkse, Mehdi Hamadani, Christopher Flowers, Jonathon B. Cohen
Journal: Blood (2016)
Safety and Efficacy Of Obinutuzumab (GA101) With Fludarabine/Cyclophosphamide (G-FC) Or Bendamustine (G-B) In The Initial Therapy Of Patients With Chronic Lymphocytic Leukemia (CLL): Results From The Phase 1b Galton Trial (GAO4779g)
Authors: Jennifer R Brown, Susan O'Brien, C Daniel Kingsley, Herbert Eradat, John M. Pagel, James Lymp, Jamie Hirata, Thomas J. Kipps
Journal: Blood (2013)
Patients (pts) with Renal Insufficiency (RI) and Multiple Myeloma (MM) Have Similar Outcomes after Autologous Hematopoietic Cell Transplantation (AHCT) As Those without
Authors: Anuj Mahindra, Parmeswaran Hari, Raphael Fraser, Mingwei Fei, Tomer Mark, Yago Nieto, Anita D'Souza
Journal: Blood (2016)
Progressed thoracic carcinoid patient experienced pregnancy, childbirth and child-raising during chemotherapy
Authors: Junji Uchida, Tanizaki Satoshi, Takahfumi Yanase, Kika Kuno, Kinnosuke Matsumoto, Takayuki Niitsu, Muneyoshi Kuroyama, Kiyonobu Ueno, Masahiko Takemura
Journal: Annals of Oncology (2019)
Identification of a Racially Dimorphic Variant in the Human Platelet PAR4 Thrombin Receptor Altering Platelet Function and Pharmacologic Inhibition
Authors: Leonard C. Edelstein, Lukas M Simon, Cory R Lindsay, Xiango Kong, Raul Teruel Montoya, Benjamin E Tourdot, Edward Chen, Lin Ma, Shaun R Coughlin, Marvin T. Nieman, Michael Holinstat, Chad Shaw, Paul F Bray
Journal: Blood (2014)
Essential Thrombin Residues for Inhibition by Plasminogen Activator Inhibitor-1 in the Absence and Presence of Heparin and Vitronectin.
Authors: Yolanda M. Fortenberry, Jill C. Rau, Lauren C. Cranford, Timothy Myles, Lawerence L. Leung, Frank C. Church
Journal: Blood (2004)
Chimerism Status Analysis after Hematopoietic Stem CellTransplantation on Granulocytes and Mononucleated Cells of Peripheral Blood
Authors: Matteo Parma, Elisa Doni, Federica Colnaghi, Arianna Colombo, Elena Elli, Pietro Pioltelli, Elisabetta Terruzzi, Enrico Maria Pogliani
Journal: Blood (2008)
Modeling of Pediatric Acute Megakaryoblastic Leukemia Using Cord Blood Stem/Progenitor Cells
Authors: Sophie Cardin, Louise Laramee, Tara MacRae, Jalila Chagraoui, Guy Sauvageau, R. Keith Humphries, Josée Hébert, Brian T. Wilhelm, Sonia Cellot
Journal: Blood (2016)
Evaluation in the Context of Daily Practice of Follicular Lymphoma patients' Outcome Before and After Approval of Rituximab in First Line Therapy in This Indication: Results of a Retrospective Analysis of 247 Unselected Patients with a 5-Year Median of Follow-up,
Authors: Emmanuelle Nicolas Virelizier, Celine Segura-Ferlay, Izabela-Irina Domnisoru, Philippe Rey, Thérèse Gargi, Catherine Chassagne-Clément, Bertrand Favier, Pierre Biron, Amine Belhabri, Catherine Sebban, Jean-Yves Blay, Herve Ghesquieres
Journal: Blood (2011)
Dasatinib (SPRYCEL®) vs Escalated Dose of Imatinib (im) in Patients (pts) with Chronic Phase Chronic Myeloid Leukemia (CP-CML) Resistant to Imatinib: Results of the CA180-017 START-R Randomized Study.
Authors: Neil Shah, R. Pasquini, P. Rousselot, S. Jootar, J. Holowiecki, A. Countouriotis, D. Dejardin, T. Hughes, Brian J. Druker
Journal: Blood (2006)
The First Single Center Phenotypic Comparison of Fanconi Anemia, Dyskeratosis Congenita, Diamond-Blackfan Anemia, and Shwachman- Diamond Syndrome: The NCI IBMFS Cohort.
Authors: Neelam Giri, Christine Mueller, Sarah Weinstein, Suvimol Hill, John Butman, Ekaterini Tsilou, Jeffrey Kim Hung, Sharon A. Savage, Blanche P. Alter
Journal: Blood (2008)
Impact of the Presence of HLA 1-Locus Mismatch and the Use of Thymoglobulin in Unrelated Bone Marrow Transplantation
Authors: Koji Kawamura, Junya Kanda, Shigeo Fuji, Kosuke Yoshioka, Yukiyasu Ozawa, Takahiro Fukuda, Naoyuki Uchida, Koji Iwato, Tatsuo Ichinohe, Yoshiko Atsuta, Yoshinobu Kanda
Journal: Blood (2016)
Cost and Efficacy of Upfront Plerixafor Versus a “Just-in-Time” (JIT) Approach in Hematopoietic Progenitor Cell (HPC) Mobilization
Authors: Lauren Westfall Veltri, Aaron Cumpston, Alexandra Shillingburg, Christopher Lipinski, Sijin Wen, Sonia Leadmon, Kathy Watkins, Michael David Craig, Mehdi Hamadani, Abraham S. Kanate
Journal: Blood (2014)
Treatment with Chimeric Antigen Receptor Modified T Cells Directed Against CD19 (CTL019) Results in Durable Remissions in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphomas of Germinal Center and Non-Germinal Center Origin, "Double Hit" Diffuse Large B Cell Lymphomas, and Transformed Follicular to Diffuse Large B Cell Lymphomas
Authors: Stephen J. Schuster, Jakub Svoboda, Sunita Dwivedy Nasta, Elise A. Chong, Nicole Winchell, Daniel J. Landsburg, David L. Porter, Anthony R. Mato, Honore T Strauser, April M. Schrank-Hacker, Mariusz A Wasik, Simon Francis Lacey, Jan Joseph Melenhorst, Anne Chew, Jens Hasskarl, Katherine T. Marcucci, Bruce L Levine, Carl H June
Journal: Blood (2016)
Notch Activation Rescues Exhaustion in CISH-Deleted Human iPSC-Derived Natural Killer Cells to Promote In Vivo Persistence and Enhance Anti-Tumor Activity
Authors: Huang Zhu, Robert Blum, Zhengming Wu, Andres Bahena, Hanna Julie Hoel, Eivind Heggernes Ask, Kun-Liang Guan, Karl-Johan Malmberg, Dan S Kaufman
Journal: Blood (2018)
A Prospective Multicenter Study of Nonmyeloablative Conditioning with TBI or Fludarabine/TBI for HLA-Matched Related Hematopoietic Cell Transplantation for Treatment of Hematologic Malignancies with Post Grafting Immunosuppression with Tacrolimus and Mycophenolate Mofetil: 10-Year Experience
Authors: Huiying Qiu, Brenda M. Sandmaier, Barry E. Storer, Thomas Chauncey, Finn Petersen, Michael A. Pulsipher, Benedetto Bruno, Mary Flowers, Marco Mielcarek, Rainer Storb, David G Maloney
Journal: Blood (2015)